Bill Willis
Bill has over three decades of developing preeminent medical device cardiology
diagnostic companies, including iRhythm (NASDAQ: IRTC), CardioNet (NASDAQ:
BEAT), Lifewatch (SIX: CARDG) and iCardia Healthcare. Bill has over 38 years in the
successful development and leadership of public and private enterprises in healthcare
industry, with an emphasis on medical device innovations in cardiac diagnostics and
digital health with seven related and issued patents. During his career, Bill was the
former President and CEO of Yor Labs, Inc. from 2017-2021 a leading edge ultrasound
technology for use in the cardiac imaging market. Prior to this, Bill was the President
of Cardiac Insight, Inc. from 2013-2017, an integrated cardiac monitoring solution
utilized in outpatient arrhythmia diagnostics. From 2006-2012, Bill served as President
and Chief Executive Officer of iRhythm Technologies, Inc. Prior to the formation of
iRhythm, Bill founded iCardia Healthcare where the first single-use device technology
was introduced. In 2003, he joined CardioNet Inc. as Executive Vice President
overseeing the national field sales, operations, finance, and administrative functions
for this cardiovascular device and clinical service company. Prior to this position he
served as President and Chief Executive Officer of LifeWatch, a wholly owned
subsidiary of Card Guard Scientific, and the nation's leading provider of cardiac
arrhythmia and holter monitoring services in the United States. Bill has held a number
of other executive management roles which include President of Coram Prescription
Services, President and Principal of Alternative Health Services, Inc., Regional Vice
President of SafeSkin Corporation and General Manager of AMSCO International. Bill
has spent his entire career in the healthcare industry; over 33 years in total, and the
last 25 of which have been devoted almost entirely to start-up ventures.